2000
[DOCID: f:s1120is.txt]
107th CONGRESS
1st Session
S. 1120
To amend the Foreign Assistance Act of 1961 to increase the
authorization of appropriations for fiscal year 2002, and to authorize
appropriations for fiscal year 2003, to combat HIV and AIDS, and for
other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
June 28, 2001
Mrs. Boxer (for herself and Mr. Smith of Oregon) introduced the
following bill; which was read twice and referred to the Committee on
Foreign Relations
_______________________________________________________________________
A BILL
To amend the Foreign Assistance Act of 1961 to increase the
authorization of appropriations for fiscal year 2002, and to authorize
appropriations for fiscal year 2003, to combat HIV and AIDS, and for
other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Global AIDS Research and Relief Act
of 2001''.
SEC. 2. DEFINITIONS.
In this Act:
(1) AIDS.--The term ``AIDS'' means the acquired immune
deficiency syndrome.
(2) Association.--The term ``Association'' means the
International Development Association.
(3) Bank.--The term ``Bank'' or ``World Bank'' means the
International Bank for Reconstruction and Development.
(4) HIV.--The term ``HIV'' means the human immunodeficiency
virus, the pathogen, which causes AIDS.
(5) HIV/AIDS.--The term ``HIV/AIDS'' means, with respect to
an individual, an individual who is infected with HIV or living
with AIDS.
SEC. 3. FINDINGS AND PURPOSES.
(a) Findings.--Congress makes the following findings:
(1) According to the Surgeon General of the United States,
the epidemic of human immunodeficiency virus/acquired immune
deficiency syndrome (HIV/AIDS) will soon become the worst
epidemic of infectious disease in recorded history, eclipsing
both the bubonic plague of the 1300s and the influenza epidemic
of 1918-1919 which killed more than 20,000,000 people
worldwide.
(2) According to the Joint United Nations Programme on HIV/
AIDS (UNAIDS), more than 36,100,000 people in the world today
are living with HIV/AIDS, of which approximately 95 percent
live in the developing world.
(3) UNAIDS data shows that among children age 15 and under
worldwide, more than 4,300,000 have died from AIDS, more than
1,400,000 are living with the disease; and in 1 year alone--
2000--an estimated 600,000 became infected, of which over 90
percent were babies born to HIV-positive women.
(4) Although sub-Saharan Africa has only 10 percent of the
world's population, it is home to more than 25,300,000--roughly
70 percent--of the world's HIV/AIDS cases.
(5) Worldwide, there have already been an estimated
21,800,000 deaths because of HIV/AIDS, of which more than 80
percent occurred in sub-Saharan Africa.
(6) According to UNAIDS, by the end of 1999, 13,200,000
children have lost at least one parent to AIDS, including
12,100,000 children in sub-Saharan Africa, and are thus
considered AIDS orphans.
(7) At current infection and growth rates for HIV/AIDS, the
National Intelligence Council estimates that the number of AIDS
orphans worldwide will increase dramatically, potentially
increasing threefold or more in the next 10 years, contributing
to economic decay, social fragmentation, and political
destabilization in already volatile and strained societies.
Children without care or hope are often drawn into
prostitution, crime, substance abuse, or child soldiery.
(8) The discovery of a relatively simple and inexpensive
means of interrupting the transmission of HIV from an infected
mother to the unborn child--namely with nevirapine (NVP), which
costs $4 a tablet--has created a great opportunity for an
unprecedented partnership between the United States Government
and the governments of Asian, African, and Latin American
countries to reduce mother-to-child transmission (also known as
``vertical transmission'') of HIV.
(9) According to UNAIDS, if implemented this strategy will
decrease the proportion of orphans that are HIV-infected and
decrease infant and child mortality rates in these developing
regions.
(10) A mother-to-child antiretroviral drug strategy can be
a force for social change, providing the opportunity and
impetus needed to address often longstanding problems of
inadequate services and the profound stigma associated with
HIV-infection and the AIDS disease. Strengthening the health
infrastructure to improve mother-and-child health, antenatal,
delivery, and postnatal services, and couples counseling
generates enormous spillover effects toward combating the AIDS
epidemic in developing regions.
(11) A January 2000 United States National Intelligence
Estimate (NIE) report on the global infectious disease threat
concluded that the economic costs of infectious diseases--
especially HIV/AIDS--are already significant and could reduce
GDP by as much as 20 percent or more by 2010 in some sub-
Saharan African nations.
(12) The HIV/AIDS epidemic is of increasing concern in
other regions of the world, with UNAIDS estimating that there
are more than 5,800,000 cases in South and Southeast Asia, that
the rate of HIV infection in the Caribbean is second only to
sub-Saharan Africa, and that HIV infections have doubled in
just 2 years in the former Soviet Union.
(13) Russia is the new ``hot spot'' for the pandemic and
more Russians are expected to be diagnosed with HIV/AIDS by the
end of 2001 than all cases from previous years combined.
(14) Despite the discouraging statistics on the spread of
HIV/AIDS, some developing nations-- such as Uganda, Senegal,
and Thailand--have implemented prevention programs that have
substantially curbed the rate of HIV infection.
(15) Accordingly, United States financial support for
medical research, education, and disease containment as a
global strategy has beneficial ramifications for millions of
Americans and their families who are affected by this disease,
and the entire population, which is potentially susceptible.
(b) Purposes.--The purposes of this Act are to--
(1) help prevent human suffering through the prevention,
diagnosis, and treatment of HIV/AIDS; and
(2) help ensure the viability of economic development,
stability, and national security in the developing world by
advancing research to--
(A) understand the causes associated with HIV/AIDS
in developing countries; and
(B) assist in the development of an AIDS vaccine.
SEC. 4. ADDITIONAL ASSISTANCE AUTHORITIES TO COMBAT HIV AND AIDS.
Paragraphs (4) through (6) of section 104(c) of the Foreign
Assistance Act of 1961 (22 U.S.C. 2151b(c)) are amended to read as
follows:
``(4)(A) Congress recognizes the growing international
dilemma of children with the human immunodeficiency virus (HIV)
and the merits of intervention programs aimed at this problem.
Congress further recognizes that m
ef8
other-to-child transmission
prevention strategies can serve as a major force for change in
developing regions, and it is, therefore, a major objective of
the foreign assistance program to control the acquired immune
deficiency syndrome (AIDS) epidemic.
``(B) The agency primarily responsible for administering
this part shall--
``(i) coordinate with UNAIDS, UNICEF, WHO, national
and local governments, other organizations, and other
Federal agencies to develop and implement effective
strategies to prevent vertical transmission of HIV; and
``(ii) coordinate with those organizations to
increase intervention programs and introduce voluntary
counseling and testing, antiretroviral drugs,
replacement feeding, and other strategies.
``(5)(A) Congress expects the agency primarily responsible
for administering this part to make the human immunodeficiency
virus (HIV) and the acquired immune deficiency syndrome (AIDS)
a priority in the foreign assistance program and to undertake a
comprehensive, coordinated effort to combat HIV and AIDS.
``(B) Assistance described in subparagraph (A) shall
include help providing--
``(i) primary prevention and education;
``(ii) voluntary testing and counseling;
``(iii) medications to prevent the transmission of
HIV from mother to child;
``(iv) programs to strengthen and broaden health
care systems infrastructure and the capacity of health
care systems in developing countries to deliver HIV/
AIDS pharmaceuticals, prevention, and treatment to
those afflicted with HIV/AIDS; and
``(v) care for those living with HIV or AIDS.
``(6)(A) In addition to amounts otherwise available for
such purpose, there is authorized to be appropriated to the
President $600,000,000 for each of the fiscal years 2002 and
2003 to carry out paragraphs (4) and (5).
``(B) Of the funds authorized to be appropriated under
subparagraph (A), not less than 65 percent is authorized to be
available through United States and foreign nongovernmental
organizations, including private and voluntary organizations,
for-profit organizations, religious affiliated organizations,
educational institutions, and research facilities.
``(C)(i) Of the funds authorized to be appropriated by
subparagraph (A), priority should be given to programs that
address the support and education of orphans in sub-Saharan
Africa, including AIDS orphans and prevention strategies for
vertical transmission referred to in paragraph (4)(A).
``(ii) Assistance made available under this subsection, and
assistance made available under chapter 4 of part II to carry
out the purposes of this subsection, may be made available
notwithstanding any other provision of law that restricts
assistance to foreign countries.
``(D) Of the funds authorized to be appropriated by
subparagraph (A), not more than 7 percent may be used for the
administrative expenses of the agency primarily responsible for
carrying out this part of this Act in support of activities
described in paragraphs (4) and (5).
``(E) Funds appropriated under this paragraph are
authorized to remain available until expended.''.
<all>
0